PARKAA paves the way

• References

• 1 Mitchell LG, Andrew M, Hanna K. et al. Trend to efficacy and safety using antithrom-bin concentrate in prevention of thrombosis in children receiving I-asparaginase for acute lymphoblastic leukemia: results of the PAR-KAA-study. Thromb Haemost 2003; 90: 235-44.
• 2 Anderson N, Lokich JJ, Tullis JL. L-asparaginase effect on antithrombin-III levels. Med Pediatr Oncol 1979; 335-40.
• 3 Priest JR, Ramsay NK, Latchaw RE. et al. Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia. Cancer 1980; 46: 1548-54.
• 4 Priest JR, Ramsay NK, Steinherz PG. et al. A syndrome of thrombosis and hemorrhage complicating Lasparaginase therapy for childhood acute lymphoblastic leukemia. J Pediatr 1982; 100: 984-9.
• 5 Bauer KA, Teitel JM, Rosenberg RD. L-asparaginase induced antithrombin III deficiency: evidence against the production of a hypercoagulable state. Thromb Res 1983; 29: 437-42.
• 6 Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998; 133: 770-6.
• 7 Male C, Chait P, Andrew M, Hanna K, Julian J, Mitchell L. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood. 2003 DOI 10.1182/blood-2002-09-2731.
• 8 Ladefoged K, Efsen F, Krogh Christoffersen J, Jarnum S. Long-term parenteral nutrition. II. Catheter-related complications. Scand J Gas-troenterol 1981; 16: 913-9.
• 9 Korones DN, Buzzard CJ, Asselin BL, Harris JP. Right atrial thrombi in children with cancer and indwelling catheters. J Pediatr 1996; 128: 841-6.
• 10 Andrew M, Marzinotto V, Pencharz P. et al. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. J Pediatr 1995; 126: 358-63.
• 11 Halton JM, Mitchell LG, Vegh P, Eves M, An-drew ME. Fresh frozen plasma has no beneficial effect on the hemostatic system in children receiving L-asparaginase. Am J Hematol 1994; 47: 157-61.
• 12 Nowak-Gottl U, Rath B, Binder M, Hassel JU, Wolff J, Husemann S, Ritter J. Inefficacy of fresh frozen plasma in the treatment of L-asparaginase- induced coagulation factor deficiencies during ALL induction therapy. Haematologica 1995; 80: 451-3.
• 13 Mitchell LG. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with Lasparaginase. Cancer 2003; 97: 508-16.
• 14 Ruud E, Holmstrom H, Natvig S, Wesen-berg F. Prevalence of thrombophilia and central venous catheter-associated neck vein thrombosis in 41 children with cancer--a pros-pective study. Med Pediatr Oncol 2002; 38: 405-10.
• 15 Wermes C, von Depka Prondzinski M, Lichtinghagen R, Barthels M, Welte K, Sykora KW. Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters. Eur J Pediatr 1999; 158 (Suppl. 03) Suppl S143-6.
• 16 Mauz-Korholz C, Nurnberger W, Irsfeld H, Korholz D, Gobel U. Low rate of severe venous thromboses in children with ALL treatment according to COALL-92 and -97 protocol. Klin Padiatr 1999; 211: 215-7.
• 17 Knofler R, Siegert E, Lauterbach I. et al. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy--impact of central venous lines. Eur J Pediatr 1999; 158 (Suppl. 03) Suppl S147-50.
• 18 Male C, Chait P, Ginsberg JS, Hanna K. et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase. Thromb Haemost 2002; 87: 593-8.
• 19 Shankar KR, Abernethy LJ, Das KS. et al. Magnetic resonance venography in assessing venous patency after multiple venous catheters. J Pediatr Surg 2002; 37: 175-9.